Deutsche Bank
JBIO

Deutsche Bank’s Jade Biosciences JBIO Stock Holding History

Deutsche Bank’s Portfolio JBIO Stock Details JBIO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$771K Sell
34,682
-4,517
-12% -$94.2K ﹤0.01% 2525
2026
Q1 		$551K Buy
39,199
+4,744
+14% +$68.7K ﹤0.01% 2529
2025
Q4 		$532K Buy
34,455
+4,859
+16% +$57K ﹤0.01% 2532
2025
Q3 		$255K Buy
29,596
+3,982
+16% +$32.5K ﹤0.01% 2932
2025
Q2 		$256K Buy
25,614
+25,475
+18,327% +$867K ﹤0.01% 2830
2025
Q1 		$12.2K Buy
139
+118
+562% +$10.4K ﹤0.01% 3493
2024
Q4 		$1.91K Buy
+21
New +$1.81K ﹤0.01% 3567
2024
Q3 		– Sell
-906
Closed -$58.4K – 3596
2024
Q2 		$52.7K Buy
906
+769
+561% +$510K ﹤0.01% 3318
2024
Q1 		$141K Sell
137
-5
-4% -$3.82K ﹤0.01% 3011
2023
Q4 		$113K Hold
142
– – ﹤0.01% 3170
2023
Q3 		$67.6K Hold
142
– – ﹤0.01% 3331
2023
Q2 		$85.5K Sell
142
-19
-12% -$12.2K ﹤0.01% 3338
2023
Q1 		$114K Buy
161
+53
+49% +$44K ﹤0.01% 3273
2022
Q4 		$111K Buy
108
+2
+2% +$1.45K ﹤0.01% 3284
2022
Q3 		$62K Sell
106
-18
-15% -$12K ﹤0.01% 3527
2022
Q2 		$68K Sell
124
-32
-21% -$15.3K ﹤0.01% 3666
2022
Q1 		$100K Sell
156
-18
-10% -$6.99K ﹤0.01% 3581
2021
Q4 		$72K Buy
174
+8
+5% +$4.05K ﹤0.01% 3838
2021
Q3 		$122K Buy
+166
New +$92.9K ﹤0.01% 3814

Other funds holding JBIO

Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
JT
Jupiter Topco New York $245B AUM
FFM
Fairmount Funds Management West Conshohocken, Pennsylvania $1.51B AUM 546.08% 1-Year Est. Return
RCM
RA Capital Management Boston, Massachusetts $11.5B AUM 168.77% 1-Year Est. Return
VA
VR Adviser New York $3.3B AUM 525.74% 1-Year Est. Return
BG
Bellevue Group Kuesnacht, Switzerland $4.75B AUM 68.58% 1-Year Est. Return
PBA
Paradigm Biocapital Advisors New York $5.34B AUM 380.18% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $462B AUM 39.16% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Deutsche Bank's JBIO Position: Q2 2026 in Review

Deutsche Bank reduced its Jade Biosciences (JBIO) stake by 12% in Q2 2026, selling an estimated $94.2K and leaving 34,682 shares worth $771K. The position accounts for ﹤0.01% of the portfolio, ranked #2525.

Deutsche Bank first reported a position in JBIO in Q3 2021 and has held it in 19 quarters since. 153 funds tracked by Wall St. Rank hold JBIO as of Q2 2026.

  • Deutsche Bank held 34,682 shares of Jade Biosciences worth $771K as of Q2 2026.
  • Deutsche Bank sold 4,517 Jade Biosciences shares in Q2 2026, an estimated $94.2K.
  • Jade Biosciences made up ﹤0.01% of Deutsche Bank's portfolio in Q2 2026, its #2525 holding.
  • Deutsche Bank first reported a position in Jade Biosciences in Q3 2021 and has held it in 19 quarters since.
  • 153 funds tracked by Wall St. Rank held Jade Biosciences as of Q2 2026.

Based on Deutsche Bank's 13F filing for Q2 2026, filed 7 Aug 2026.